SAP SE vs Novartis AG
Market cap comparison over time
SAP SE
$243.2B
Rank #63
Novartis AG
$255.0B
Rank #59
Market Cap Over Time
Key Moments
- SAP SE overtook Novartis AG by 1999
- Novartis AG overtook SAP SE by 2000
- SAP SE overtook Novartis AG by 2012
- Novartis AG overtook SAP SE by 2014
- SAP SE overtook Novartis AG by 2017
- Novartis AG overtook SAP SE by 2018
- SAP SE overtook Novartis AG by 2020
- Novartis AG overtook SAP SE by 2022
- SAP SE overtook Novartis AG by 2023
- Novartis AG overtook SAP SE by 2026
Year-by-Year Comparison
| Year | SAP SE | Novartis AG | Leader |
|---|---|---|---|
| 2026 | $243.2B | $255.0B | Novartis AG |
| 2025 | $278.8B | $227.3B | SAP SE |
| 2024 | $280.0B | $177.6B | SAP SE |
| 2023 | $173.6B | $163.8B | SAP SE |
| 2022 | $114.0B | $146.3B | Novartis AG |
| 2021 | $150.4B | $134.5B | SAP SE |
| 2020 | $137.7B | $134.7B | SAP SE |
| 2019 | $139.5B | $142.4B | Novartis AG |
| 2018 | $102.2B | $110.8B | Novartis AG |
| 2017 | $113.7B | $104.0B | SAP SE |
| 2016 | $86.3B | $89.6B | Novartis AG |
| 2015 | $77.7B | $100.4B | Novartis AG |
| 2014 | $67.3B | $103.4B | Novartis AG |
| 2013 | $82.7B | $76.6B | SAP SE |
| 2012 | $75.2B | $59.2B | SAP SE |
| 2011 | $48.3B | $52.5B | Novartis AG |
| 2010 | $45.5B | $51.1B | Novartis AG |
| 2009 | $41.5B | $50.7B | Novartis AG |
| 2008 | $31.5B | $44.5B | Novartis AG |
| 2007 | $43.8B | $50.6B | Novartis AG |
| 2006 | $45.0B | $55.9B | Novartis AG |
| 2005 | $37.9B | $53.9B | Novartis AG |
| 2004 | $36.9B | $43.8B | Novartis AG |
| 2003 | $34.4B | $42.0B | Novartis AG |
| 2002 | $16.1B | $36.9B | Novartis AG |
| 2001 | $26.2B | $43.1B | Novartis AG |
| 2000 | $27.6B | $50.7B | Novartis AG |
| 1999 | $42.5B | $40.7B | SAP SE |
| 1998 | $29.3B | $46.3B | Novartis AG |
| 1997 | $21.6B | $40.1B | Novartis AG |
| 1996 | $9.4B | $24.5B | Novartis AG |
| 1995 | $10.4B | $16.9B | Novartis AG |